Osteoarthritis Trial, Recruiting NCT06493903 Sponsor: Boston University Charles River Campus Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06493903
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older
  • People with a body mass index (a measure of weight relative to height) of 40 or below
  • People who self-identify as Black, including African American
  • People who have had knee pain rated at least 4 out of 10 on average over the past week
  • People who have scored 5 or more on a standard depression questionnaire (PHQ-9) and/or a standard anxiety questionnaire (GAD-7)
  • People who can speak and understand English well enough to follow study instructions and sign a consent form
  • People who are available for the full length of the study
  • People who are able to attend sessions held remotely (such as by video or phone)

Who may not be able to join:

  • People who have had a knee, hip, or ankle replacement
  • People who have had a steroid or hyaluronic acid injection into the knee within the past 3 months
  • People who have had knee surgery within the past 6 months
  • People who are currently receiving, or have received within the past 3 months, physical therapy for knee osteoarthritis
  • People who are currently receiving, or have received within the past 3 months, any non-medication mental health treatment
  • People who are planning to start physical therapy for joint or lower back pain within the next 3 months
  • People who are planning to start any non-medication mental health treatment within the next month
  • People with inflammatory arthritis conditions such as rheumatoid arthritis
  • People with neurological conditions such as stroke or Parkinson's disease
  • People for whom starting an exercise program would not be medically safe (confirm with trial site)
  • People with suspected substance abuse issues
  • People who are not able to give informed consent on their own behalf
  • People who are pregnant
  • People already taking part in another clinical trial for joint or muscle pain
  • People planning to have a major surgery within the next 6 months
  • People experiencing high-risk mental health symptoms, including active suicidal thoughts, bipolar disorder, mania, psychosis, or schizophrenia
  • People currently receiving chemotherapy or radiation therapy for cancer, except for non-melanoma skin cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-358-3037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University Charles River Campus
Registry
ClinicalTrials.gov
Start date
17 February 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment Rate; Retention; Attendance; Satisfaction with treatment; Participant Feedback

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov